OHM Laboratories Inc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: OHM Laboratories Inc Pharmaceutical Import Records from India — 7 Products, $9.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

OHM Laboratories Inc — Pharmaceutical Importer Profile (2026) | 7 Products, $9.5M Trade | TransData Nexus

OHM Laboratories Inc

Pharmaceutical Importer · United States · Antihistamines & Allergy Focus · $9.5M Total Trade · DGFT Verified

OHM Laboratories Inc is a pharmaceutical importer based in United States with a total trade value of $9.5M across 7 products in 3 therapeutic categories. Based on 208 verified import shipments from Indian Customs (DGFT) records, OHM Laboratories Inc is the #1 buyer in 1 product including Pseudoephedrine. OHM Laboratories Inc sources from 1 verified Indian supplier, with Sun Pharmaceutical Industries Limited accounting for 100.0% of imports.

OHM Laboratories Inc — Import Portfolio & Supplier Network

OHM Laboratories Inc import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to OHM Laboratories Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$13.0M	425	100.0%

OHM Laboratories Inc sources from 1 verified Indian supplier across 223 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does OHM Laboratories Inc Import?

Formulation	Value	Ships
Omeprazole delayed release tablets 20MG	$1.3M	36
Cetirizine hcl and pseudoephedrine hcl.	$650.0K	13
Omeprazole delayed release tablets 20mgpack : 03*14 (batch no as per invoice)	$547.3K	13
Fexofenadine hydrochloride tablets USP	$415.1K	14
Omeprazole delayed release tablets	$283.8K	6
Omeprazole delayed release tablets 20 mg42ct (curist) Pack : 03*14 (batch no asper invoice)	$219.8K	6
Omeprazole delayed release tabs 20 MG	$214.0K	5
Omeprazole 20MG dr TAB 42ct Pack	$203.8K	6
Fexofenadine hydrochloride 60MG and	$200.0K	4
Fexofenadine 180MG tabs 150ct - ohm	$200.0K	4
Omeprazole delayed release tabs 20 MG	$173.5K	4
Levonorgestrel tablets 1.5 MG Pack : stp1 t/c batch : hae2903a mfd : 27.12.2023exp	$150.0K	3
Levonorgestrel tablets 1.5	$150.0K	3
Fexofenadine hydrochloride tablets USP 180MG 150ct Pack : bt 150 t/c (batch no as per invoice)	$150.0K	3
Levonorgestrel tablets 1.5 MG [131170 Pack x stp 1	$150.0K	3

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fexofenadine	Antihistamines & Allergy	$3.6M	79	2.2%	12
2	Ephedrine	Respiratory & OTC	$1.9M	37	6.2%	2
3	Pseudoephedrine	Respiratory & OTC	$1.9M	37	11.7%	1
4	Cetirizine	Antihistamines & Allergy	$1.3M	25	0.7%	13
5	Guaifenesin	Respiratory & OTC	$514.1K	22	1.9%	12
6	Strip	Medical Devices & Diagnostics	$250.0K	5	0.1%	14
7	Dextromethorphan	Respiratory & OTC	$150.0K	3	1.0%	15

OHM Laboratories Inc imports 7 pharmaceutical products across 3 categories into United States totaling $9.5M. The company is the #1 buyer for 1 product: Pseudoephedrine.

OHM Laboratories Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

OHM Laboratories Inc is a pharmaceutical importer and buyer based in the United States, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Established in 1981 and headquartered in New Brunswick, New Jersey, OHM Laboratories has been a significant player in the U.S. pharmaceutical distribution network. In 1995, the company was acquired by Ranbaxy Laboratories, which was subsequently acquired by Sun Pharmaceutical Industries in 2014, integrating OHM Laboratories into Sun Pharma's global operations. (cdek.pharmacy.purdue.edu)

As a subsidiary of Sun Pharma, OHM Laboratories Inc plays a pivotal role in sourcing and importing a diverse range of pharmaceutical products, ensuring the availability of essential medications in the U.S. market. The company's operations are integral to Sun Pharma's distribution strategy, facilitating the delivery of high-quality, affordable medications to healthcare providers and patients across the United States.

2Distribution Network

OHM Laboratories Inc operates a comprehensive distribution network within the United States, with facilities located in New Brunswick, New Jersey, and Princeton, New Jersey. These strategically positioned facilities enable efficient logistics and supply chain management, ensuring timely delivery of pharmaceutical products to various regions. The company's distribution capabilities are further enhanced by its integration with Sun Pharmaceutical Industries, leveraging Sun Pharma's extensive global logistics infrastructure to support its operations.

3Industry Role

In the U.S. pharmaceutical supply chain, OHM Laboratories Inc functions primarily as a pharmaceutical importer and buyer, sourcing finished pharmaceutical formulations from international suppliers, particularly from India. The company's role is crucial in ensuring the availability of a wide array of generic medications, contributing to the affordability and accessibility of healthcare in the United States. By importing these products, OHM Laboratories Inc supports the U.S. market with a steady supply of essential drugs, thereby enhancing the overall efficiency and resilience of the pharmaceutical supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — OHM Laboratories Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

OHM Laboratories Inc demonstrates a high degree of sourcing concentration, with a total import value of $9.5 million USD from India, comprising 208 shipments across seven products in three therapeutic categories. Notably, the company imports 95.8% of its products from a single supplier, SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for $13.0 million USD in imports over 425 shipments. (cdek.pharmacy.purdue.edu)

This single-source dependency indicates a strategic choice to maintain a streamlined supply chain and potentially leverage favorable terms with a primary supplier. However, such concentration also poses risks, including vulnerability to supply disruptions or changes in supplier dynamics. The stability of this relationship is critical, and the absence of alternative suppliers may impact OHM Laboratories Inc's ability to mitigate potential supply chain challenges.

2Supply Chain Resilience

The resilience of OHM Laboratories Inc's Indian supply chain is closely tied to its exclusive partnership with SUN PHARMACEUTICAL INDUSTRIES LIMITED. The lack of backup suppliers for the imported formulations suggests a potential vulnerability in the event of supply disruptions. Additionally, the company's reliance on a single supplier may limit its ability to diversify its product offerings or respond to market changes effectively.

Shipping route exposure is also a consideration, as reliance on specific logistics channels can be susceptible to geopolitical or logistical challenges. Regulatory compliance of SUN PHARMACEUTICAL INDUSTRIES LIMITED is paramount, and any lapses could directly affect OHM Laboratories Inc's operations. Ensuring that SUN PHARMACEUTICAL INDUSTRIES LIMITED adheres to all relevant regulatory standards is essential for maintaining the integrity and reliability of the supply chain.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug imports, ensuring that all imported drugs meet standards for quality, safety, and effectiveness.

The FDA's importation policies are designed to protect public health by promoting supply chain integrity and ensuring that medicines imported into the U.S. comply with applicable legal and regulatory requirements. Imported drugs must meet FDA standards, and the agency reviews shipments to determine their admissibility into the U.S. market. Drugs that are adulterated, misbranded, or unapproved may be refused entry.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. All foreign drug establishments whose products are imported must register with the FDA and list all their drug products in commercial distribution in the U.S. This registration ensures that the FDA is notified of all regulated products imported into the United States.

Good Manufacturing Practice (GMP) certification is a critical component of the import process. The FDA recognizes GMP certifications from various international standards, including EU GMP, WHO GMP, and PIC/S. These certifications attest to the quality and safety of pharmaceutical products. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products, ensuring compliance with federal and state regulations.

OHM Laboratories Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

OHM Laboratories Inc's product category focus on antihistamines, respiratory and over-the-counter (OTC) medications, and medical devices and diagnostics aligns with prevalent health concerns in the United States. The high import values of products like Pseudoephedrine, Ephedrine, and Fexofenadine indicate a strategic emphasis on addressing respiratory issues and allergies, which are common among the U.S. population. The inclusion of medical devices and diagnostics in their portfolio suggests a comprehensive approach to healthcare, catering to both therapeutic and diagnostic needs.

The market demand for these products is driven by the widespread prevalence of allergic conditions, respiratory disorders, and the need for accessible diagnostic tools. By focusing on these therapeutic areas, OHM Laboratories Inc positions itself to meet significant healthcare needs, ensuring a steady demand for its imported products.

2Sourcing Profile

OHM Laboratories Inc's sourcing strategy is centered on importing generic drug formulations from India, leveraging the country's robust pharmaceutical manufacturing capabilities. The company's preference for finished pharmaceutical formulations over raw active pharmaceutical ingredients (APIs) indicates a focus on ready-to-market products, streamlining the supply chain and reducing time to market. India's established reputation for producing high-quality generic medications aligns with OHM Laboratories Inc's procurement objectives.

Frequently Asked Questions — OHM Laboratories Inc

What products does OHM Laboratories Inc import from India?

OHM Laboratories Inc imports 7 pharmaceutical products across 3 categories. Top imports: Fexofenadine ($3.6M), Ephedrine ($1.9M), Pseudoephedrine ($1.9M), Cetirizine ($1.3M), Guaifenesin ($514.1K).

Who supplies pharmaceuticals to OHM Laboratories Inc from India?

OHM Laboratories Inc sources from 1 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (100.0% of imports, $13.0M).

What is OHM Laboratories Inc's total pharmaceutical import value?

OHM Laboratories Inc's total pharmaceutical import value from India is $9.5M, based on 208 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does OHM Laboratories Inc focus on?

OHM Laboratories Inc imports across 3 categories. The largest: Antihistamines & Allergy (51.4%), Respiratory & OTC (46.0%), Medical Devices & Diagnostics (2.6%).

Get Full OHM Laboratories Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

OHM Laboratories Inc

OHM Laboratories Inc — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to OHM Laboratories Inc?

What Formulations Does OHM Laboratories Inc Import?

What Products Does OHM Laboratories Inc Import?

Top Products by Import Value

OHM Laboratories Inc Therapeutic Categories — 3 Specializations